GWM Advisors LLC lifted its stake in AmerisourceBergen Corp. (NYSE:ABC) by 48.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,916 shares of the company’s stock after buying an additional 2,577 shares during the period. GWM Advisors LLC’s holdings in AmerisourceBergen were worth $767,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vantage Investment Advisors LLC purchased a new position in shares of AmerisourceBergen in the fourth quarter worth about $156,000. IFG Advisory LLC purchased a new position in AmerisourceBergen during the 4th quarter valued at about $678,000. Intl Fcstone Inc. purchased a new position in AmerisourceBergen during the 2nd quarter valued at about $201,000. TRUE Private Wealth Advisors purchased a new position in AmerisourceBergen during the 4th quarter valued at about $203,000. Finally, IBM Retirement Fund purchased a new position in AmerisourceBergen during the 4th quarter valued at about $216,000. Hedge funds and other institutional investors own 66.84% of the company’s stock.
Shares of AmerisourceBergen Corp. (NYSE:ABC) opened at $99.40 on Friday. The company has a current ratio of 0.95, a quick ratio of 0.50 and a debt-to-equity ratio of 1.61. The firm has a market capitalization of $21,439.70, a P/E ratio of 16.05, a price-to-earnings-growth ratio of 1.56 and a beta of 1.02. AmerisourceBergen Corp. has a 12-month low of $71.90 and a 12-month high of $106.27.
AmerisourceBergen (NYSE:ABC) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $1.55 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.35 by $0.20. The business had revenue of $40.47 billion for the quarter, compared to analysts’ expectations of $40.42 billion. AmerisourceBergen had a return on equity of 53.65% and a net margin of 0.66%. The business’s revenue was up 6.0% on a year-over-year basis. During the same period in the previous year, the firm posted $1.36 EPS. equities research analysts anticipate that AmerisourceBergen Corp. will post 6.58 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 5th. Shareholders of record on Tuesday, February 20th will be given a dividend of $0.38 per share. The ex-dividend date of this dividend is Friday, February 16th. This represents a $1.52 annualized dividend and a yield of 1.53%. AmerisourceBergen’s payout ratio is 32.76%.
In other AmerisourceBergen news, CFO Tim G. Guttman sold 11,600 shares of AmerisourceBergen stock in a transaction that occurred on Monday, December 4th. The stock was sold at an average price of $85.73, for a total transaction of $994,468.00. Following the sale, the chief financial officer now directly owns 56,436 shares of the company’s stock, valued at approximately $4,838,258.28. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Chairman Steven H. Collis sold 21,350 shares of AmerisourceBergen stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $82.53, for a total value of $1,762,015.50. Following the sale, the chairman now directly owns 287,925 shares in the company, valued at $23,762,450.25. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 205,355 shares of company stock worth $18,519,104. Insiders own 27.30% of the company’s stock.
A number of research analysts recently issued reports on ABC shares. Credit Suisse Group restated an “outperform” rating and set a $112.00 price target (up previously from $105.00) on shares of AmerisourceBergen in a report on Wednesday, February 7th. They noted that the move was a valuation call. Needham & Company LLC boosted their price target on AmerisourceBergen from $86.00 to $88.00 and gave the company a “buy” rating in a report on Wednesday, November 22nd. Mizuho set a $100.00 price target on AmerisourceBergen and gave the company a “hold” rating in a report on Wednesday, January 24th. Robert W. Baird restated a “buy” rating and set a $96.00 price target on shares of AmerisourceBergen in a report on Monday, November 6th. Finally, TheStreet upgraded AmerisourceBergen from a “c” rating to a “b” rating in a report on Tuesday, February 6th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. AmerisourceBergen has an average rating of “Buy” and a consensus target price of $101.17.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.